BridgeBio Oncology Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $332.9K
Liabilities Breakdown FY2023
Total Liabilities: $396.5K
Asset Breakdown
Total Assets: $332.9K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $250.0K | 75.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $82.9K | 24.9% |
Liabilities Breakdown
Total Liabilities: $396.5K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $396.5K | 100.0% |